CompoAtlas

MEDELAID

Natural health product licensed in Canada

Licence holder
Medelys Laboratoires International Inc.
NPN or DIN-HM
80023417
Status
Active licence
Licence date
21 January 2011
Revision date
Not provided
Form
Liquide
Route of administration
Topique
Application type
TPD Cat IV/LS

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Huile essentielle d'eucalyptus

Source : Huile essentielle d'eucalyptus

1.5 %
(1R, 2S, 5R)-5-méthyl-2-(1-méthyléthyl)cyclohexanol

Source : Menthol

6 %

Non-medicinal ingredients

Menthe poivrée, Eau, Lavande, Camphre, Alcool isopropylique

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 2 years1 Pulvérisateurminimum: 3 Time Unit TBA ; maximum: 4 Time Unit TBA
AdultesNot specified1 Pulvérisateurminimum: 3 Time Unit TBA ; maximum: 4 Time Unit TBA

Uses authorised in Canada

Vaporisateur externe pour le soulagement temporaire de la douleur et les courbatures des muscles et des articulations associées au : mal de dos, lumbago, contusions, foulure/entorse (impliquant les muscles, les tendons, et/ou les ligaments), et la douleur arthritique.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80023417

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line